Tri Locum Partners LP Makes New Investment in The Cigna Group (NYSE:CI)

Tri Locum Partners LP bought a new stake in The Cigna Group (NYSE:CI - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 40,810 shares of the health services provider's stock, valued at approximately $11,269,000. The Cigna Group comprises approximately 2.3% of Tri Locum Partners LP's investment portfolio, making the stock its 19th largest position.

A number of other large investors also recently made changes to their positions in the company. TCTC Holdings LLC purchased a new stake in shares of The Cigna Group during the 4th quarter valued at $25,000. Collier Financial bought a new position in The Cigna Group during the fourth quarter valued at about $32,000. ORG Wealth Partners LLC purchased a new stake in The Cigna Group during the fourth quarter worth about $34,000. Compagnie Lombard Odier SCmA purchased a new stake in The Cigna Group during the fourth quarter worth about $37,000. Finally, Transce3nd LLC bought a new stake in The Cigna Group in the fourth quarter worth about $38,000. 86.99% of the stock is owned by institutional investors.

Insider Transactions at The Cigna Group

In related news, CEO David Cordani sold 26,527 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now directly owns 127,767 shares of the company's stock, valued at approximately $39,367,568.04. This represents a 17.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Elder Granger sold 2,376 shares of the company's stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $310.35, for a total transaction of $737,391.60. Following the completion of the transaction, the director now owns 5,471 shares in the company, valued at approximately $1,697,924.85. This represents a 30.28 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,751 shares of company stock valued at $13,603,991 in the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently issued reports on CI. Truist Financial raised their price target on shares of The Cigna Group from $375.00 to $385.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Sanford C. Bernstein downgraded The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 target price for the company. in a research report on Thursday, February 6th. Cantor Fitzgerald upped their price target on The Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a research report on Thursday, March 20th. Raymond James reiterated a "strong-buy" rating and set a $360.00 price target (down previously from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Finally, Stephens lowered their price objective on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating on the stock in a research note on Friday, January 31st. Two research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and three have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $373.56.

The Cigna Group Stock Down 0.0 %

Shares of NYSE:CI opened at $335.60 on Friday. The firm has a market capitalization of $91.85 billion, a P/E ratio of 27.42, a P/E/G ratio of 0.98 and a beta of 0.51. The stock has a 50 day moving average price of $319.82 and a 200-day moving average price of $310.44. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66.

The Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the prior year, the firm posted $6.79 EPS. As a group, equities research analysts anticipate that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be given a $1.51 dividend. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.80%. The Cigna Group's dividend payout ratio is currently 49.35%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.